Dr Stephen O'Flaherty
Rehabilitation Paediatrician MB ChB, FAFRM, FRACP
Medico-legal assessments on children and adolescents with Cerebral Palsy or Acquired Brain Injury
Dr Stephen O'Flaherty has provided clinical care and medico-legal reports on children and adolescents over a period of 30 years in the areas of Cerebral Palsy and Acquired Brain Injury. The major areas of emphasis of the medico-legal assessments are on current issues, long term outcome and future needs. Dr O'Flaherty is based in Sydney, NSW.
Dr O'Flaherty is a member of the following medical bodies:
-
American Academy of Cerebral Palsy & Developmental Medicine
-
Australasian Academy of Cerebral Palsy & Developmental Medicine
-
Australian Medical Association
Experience
Cerebral Palsy
-
Established clinical service for management and treatment of children and adolescents with Cerebral Palsy and managed over 500 children over a 30 year period, initially with 13 years at Westmead Hospital and then 17 years at Children's Hospital at Westmead, NSW, Australia as head of Paediatric Rehabilitation.
-
Extensive expertise in assessing suitability for treatment using Botulinum Toxin Injections for management of the movement problems associated with Cerebral Palsy.
-
Expertise in overseeing the long-term management of children with Cerebral Palsy throughout childhood and adolescence.
Acquired Brain Injury
-
Extensive experience in managing inpatients with acute acquired brain injury from traumatic and medical conditions and outpatients for their long term management also over a period of 30 years.
Medico-legal Reports
-
Production of medico-legal reports on patients for insurers and solicitors for over 30 years.
Present and Past Appointments
Dec 2023 - Present
Honorary Medical Officer in Paediatric Rehabilitation
Sydney Children's Hospital RANDWICK, NSW
Consultative role in the Cerebral Palsy Service including the Botulinum Toxin Clinic
2014 - Nov 2023
Senior Staff Specialist
in Paediatric Rehabilitation
Sydney Children's Hospital RANDWICK, NSW
Clinical activities are in Cerebral Palsy Management Clinic & Botulinum Toxin assessment and administration.
2015 - 2018
Honorary Visiting Medical
Officer in Paediatric
Rehabilitation
John Hunter Children's Hospital NEWCASTLE, NSW
Clinical activities are in managing movement disorders of children and adolescents with Cerebral Palsy with Botulinum Toxin.
2013 - 2015
Locum Senior Staff Specialist
John Hunter Children's Hospital NEWCASTLE, NSW
Clinical activities were in assessing children and adolescents with Cerebral Palsy and managing their movement disorders with Botulinum Toxin.
1995 - 2012
Senior Staff Specialist and Head of Department of Paediatric Rehabilitation
Children's Hospital at Westmead WESTMEAD, NSW
Clinical activities included managing children and adolescents with Cerebral Palsy and Acquired Brain Injury, and establishing the clinical services for managing movement disorders with Botulinum Toxin, Selective Dorsal Rhisotomy (SDR) and Intrathecal Baclofen (ITB).
1982 - 1995
Staff Specialist and
Head of Department of
Paediatric Rehabilitation
Westmead Hospital WESTMEAD, NSW
Clinical activities included managing children and adolescents with Cerebral Palsy and Acquired Brain Injury.
Personal Publications (curated)
Main Author
-
Outcome after Traumatic Brain Injury in Children European Journal of Neurology 3 (Supp3), May 1996 6 – abstract,
-
A Comprehensive Paediatric Brain Injury Rehabilitation Service European Journal of Neurology 3 (Supp3), May 1996 65 – abstract,
-
Medically Compromised Children. Chapter in ‘Handbook of Pediatric Dentistry’ Eds. Cameron A and Widmer R. Mosby-Wolfe, London, 1997
-
Botulinum Toxin for mobilising Kids Abstract/poster, SHPA meeting, Nov 1997
-
Progression from Paediatric to Adult Services for Adolescents with Disability Annual (7th) Scientific Meeting of AFRM, Adelaide, Abstract, March 1999
-
Botulinum Toxin Clinic at New Children’s Hospital abstract, Juvenile Cerebral Palsy Conference, Melbourne, Jan 1999 28-30
-
The Westmead Paediatric TBI Multidisciplinary Outcome Study: Use of Functional Outcome Data to Determine Resource Prioritisation Archives of Physical Medicine and Rehabilitation, Jun 2000 81(6):723-9
-
Neuro-Rehabilitation of Children after TBI invited Speaker, World Congress (3rd) in Neurological Rehabilitation, Venice, Italy, April 2002 2-6, abstract,
-
Neurorehabilitation for Children in Australia Invited article, World Federation for Neurorehabilitation Update, Feb 2003
-
Botulinum toxin A adverse events and health status in children with cerebral palsy in all GMFCS levels Developmental Medicine & Child Neurology, 2011 Feb;; 5 (2)::125-130,
-
Current Australian clinical practice in the use of Botulinum Toxin-A to manage Paediatric Hypertonicity Journal Paediatrics and Child Health. 2021 Oct;57 (10): 1662-1665
Co-Author
-
Neurological Deterioration following head injury: The eyes had it Journal of Paediatrics and Child Health, Apr 1998 34(2):202-5,
-
Autonomic Dysfunction after Paediatric Traumatic Brain Injury: Management & Outcome Abstract, ACRM Annual Meeting, Dunedin NZ, 1994
-
Upper Limb function in Australian children with traumatic brain injury: A controlled, prospective study Archives Physical Medicine & Rehabilitation, 2001 82:642-9,
-
Functional outcomes of botulinum toxin A injections in the upper limbs of children with cerebral palsy: A pilot study Developmental Medicine & Child Neurology, 2001 43, 88 (Suppl) 9,
-
Continuous intrathecal baclofen infusion for children with cerebral palsy: A pilot study Journal Paediatrics & Child Health, Jun 2001 37, 283-288,
-
Functional outcomes of intramuscular Botulinum toxin A in the upper limbs of children with cerebral palsy: A pilot project Suppl, Developmental Medicine & Child Neurology, Sep 2002
-
Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy Hand Clinics, 2003 19: 585-9,
-
Functional outcomes of intramuscular Botulinum toxin A in the upper limbs of children with cerebral palsy: A Phase II trial Archives of Physical & Rehabilitation, 2004 85: 192-200
-
Randomised placebo controlled crossover study of the effectiveness of oral baclofen in children with spasticity and cerebral palsy Abstract, Annual (7th) Scientific Meeting of AFRM, Hobart, 2004
-
Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy ,Developmental Medicine & Child Neurology, 2006 48,11, 883-887
-
Letter: Response to “Botulinum neurotoxin A: an unusual systemic effect Journal of Paediatrics and Child Health 11, 2008 468-9,
-
Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international statement European Journal of Neurol,ogy 2010 17 (s2), 9-37,
-
Conscious Sedation or General Anaesthetic for Intramuscular Botulinum Toxin Injections in Children - A Two Centre Cross-Sectional Prospective Audit European Journal of Paediatric Neurology 2011, 16: 215-217,
-
Systemic adverse effects after botulinum neurotoxin A injections in children with cerebral palsy Developmental Medicine and Child Neurology. 2018, 60 (11) 1172-1177
-
Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections . Developmental Medicine & Child Neurology, 2018 60 (5) 498-504 ,
Major Presentations (curated)
2002 Invited Speaker
World Congress (3rd) in Neurological Rehabilitation. Venice, Italy. “Neuro-rehabilitation of children after Traumatic Brain Injury”
2008 Invited Speaker
Hôpital Universitaire de la Pitié-Salpêtrière, Grand Rounds. “Managing movement disorders in children with Cerebral Palsy – the Sydney experience”
2021 Presidential Address
Australasian Academy of Cerebral Palsy and Developmental Medicine. “Paediatric Rehabilitation"
Dr Stephen O'Flaherty
Dr O'Flaherty is currently taking on work on a case by case basis. Terms and cv will be sent on request.
APHRA Registration: MED0000942476 ABN 58938145849